Royalty Pharma plc

Q2 2026 13F Holders

Symbol
RPRX
CUSIP
G7709Q104
Type
Equity
Class
SHS CLASS A
Num filings
666
Total reported value, excl. options
$21.3 B
Manager Report Date Value ($000) Shares Option Type